412 related articles for article (PubMed ID: 15735128)
1. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.
Mamon HJ; Yeap BY; Jänne PA; Reblando J; Shrager S; Jaklitsch MT; Mentzer S; Lukanich JM; Sugarbaker DJ; Baldini EH; Berman S; Skarin A; Bueno R
J Clin Oncol; 2005 Mar; 23(7):1530-7. PubMed ID: 15735128
[TBL] [Abstract][Full Text] [Related]
2. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
4. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy.
Germain F; Wai ES; Berthelet E; Truong PT; Lesperance M
Am J Clin Oncol; 2008 Dec; 31(6):561-6. PubMed ID: 19060588
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ;
J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657
[TBL] [Abstract][Full Text] [Related]
6. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
[TBL] [Abstract][Full Text] [Related]
7. Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?
Park BB; Park JO; Kim H; Ahn YC; Choi YS; Kim K; Kim J; Shim YM; Ahn JS; Park K
Lung Cancer; 2006 Sep; 53(3):323-30. PubMed ID: 16844258
[TBL] [Abstract][Full Text] [Related]
8. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?
Carolan H; Sun AY; Bezjak A; Yi QL; Payne D; Kane G; Waldron J; Leighl N; Feld R; Burkes R; Keshavjee S; Shepherd F
Lung Cancer; 2005 Jul; 49(1):109-15. PubMed ID: 15949596
[TBL] [Abstract][Full Text] [Related]
9. Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer.
Wang SY; Ye X; Ou W; Lin YB; Zhang BB; Yang H
Lung Cancer; 2009 May; 64(2):238-43. PubMed ID: 18838190
[TBL] [Abstract][Full Text] [Related]
10. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
11. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
[TBL] [Abstract][Full Text] [Related]
12. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis.
Ceresoli GL; Reni M; Chiesa G; Carretta A; Schipani S; Passoni P; Bolognesi A; Zannini P; Villa E
Cancer; 2002 Aug; 95(3):605-12. PubMed ID: 12209754
[TBL] [Abstract][Full Text] [Related]
13. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
[TBL] [Abstract][Full Text] [Related]
14. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits.
Doddoli C; Barlesi F; Trousse D; Robitail S; Yena S; Astoul P; Giudicelli R; Fuentes P; Thomas P
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):416-25. PubMed ID: 16077407
[TBL] [Abstract][Full Text] [Related]
15. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
16. Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer.
Takeda S; Maeda H; Okada T; Yamaguchi T; Nakagawa M; Yokota S; Sawabata N; Ohta M
Eur J Cardiothorac Surg; 2006 Jul; 30(1):184-9. PubMed ID: 16730452
[TBL] [Abstract][Full Text] [Related]
17. Resection of brain metastases from non-small-cell lung carcinoma. Results of therapy. Memorial Sloan-Kettering Cancer Center Thoracic Surgical Staff.
Burt M; Wronski M; Arbit E; Galicich JH
J Thorac Cardiovasc Surg; 1992 Mar; 103(3):399-410; discussion 410-1. PubMed ID: 1312184
[TBL] [Abstract][Full Text] [Related]
18. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
Martin LW; Correa AM; Hofstetter W; Hong WK; Komaki R; Putnam JB; Rice DC; Smythe WR; Swisher SG; Vaporciyan AA; Walsh GL; Roth JA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1601-10. PubMed ID: 16308005
[TBL] [Abstract][Full Text] [Related]
19. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group.
Gaspar LE; Chansky K; Albain KS; Vallieres E; Rusch V; Crowley JJ; Livingston RB; Gandara DR
J Clin Oncol; 2005 May; 23(13):2955-61. PubMed ID: 15860851
[TBL] [Abstract][Full Text] [Related]
20. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]